0001144204-19-029286.txt : 20190531 0001144204-19-029286.hdr.sgml : 20190531 20190531171735 ACCESSION NUMBER: 0001144204-19-029286 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190531 DATE AS OF CHANGE: 20190531 EFFECTIVENESS DATE: 20190531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cellectar Biosciences, Inc. CENTRAL INDEX KEY: 0001279704 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043321804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-340882 FILM NUMBER: 19871429 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (608) 441-8120 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: NOVELOS THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050617 FORMER COMPANY: FORMER CONFORMED NAME: COMMON HORIZONS INC DATE OF NAME CHANGE: 20040211 D 1 primary_doc.xml X0708 D LIVE 0001279704 Cellectar Biosciences, Inc. 100 CAMPUS DRIVE FLORHAM PARK NJ NEW JERSEY 07932 (608) 441-8120 DELAWARE Novelos Therapeutics, Inc. Commons Horizons Inc. NOVELOS THERAPEUTICS, INC. COMMON HORIZONS INC Corporation true Charles T. Bernhardt c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Executive Officer James V. Caruso c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Executive Officer Director Frederick W Driscoll c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Director Stephen A. Hill c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Director Stefan Loren c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Director John Neis c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Director Douglas J. Swirsky c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Director Jarrod Longcor c/o Cellectar Biociences, Inc. 100 Campus Drive Florham Park NJ NEW JERSEY 07932 Executive Officer Pharmaceuticals No Revenues 06b false 2019-05-20 false true true false 0 Roth Capital Partners, LLC 15407 None None 888 SAN CLEMENTE DRIVE NEWPORT BEACH CA CALIFORNIA 92660 CA CALIFORNIA FL FLORIDA IL ILLINOIS false 14645000 5045000 9600000 The $9.6 million remaining to be sold are 4,000,000 warrants with an exercise price of $2.40 per share, only to the extent such warrants are exercised. Does not include a $4,955,000 concurrent registered offering. false 11 378375 0 Sales commissions relates to commissions for the sale of common stock and warrants in the private placement. 0 false Cellectar Biosciences, Inc. /s/ Charles T. Bernhardt Charles T. Bernhardt Interim Chief Financial Officer 2019-05-31